相关实验视频
Updated: Jan 11, 2026

04:09
Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
Published on: September 20, 2024
797
从抵抗到缓解:IV勒沃甲状腺素在耐药性甲状腺功能低下症管理中的治疗方法
Mohammad Amro1, Elias Edward Lahham2, Ahmed Jalal Sawafta1
1Faculty of Medicine An Najah National University Nablus Palestine.
Clinical case reports
|November 11, 2025
概括
这份病例报告强调了一名患有异常性耐药性甲状腺功能低下症的患者,该患者对口服levothyroxine没有反应. 静脉输入的levothyroxine治疗导致症状完全消失和持续的甲状腺状态.
科学领域:
- 内分泌学 在内分泌学.
- 内部医学 内部医学
背景情况:
- 异形性耐火性甲状腺功能低下症带来了诊断和治疗方面的挑战.
- 患者可能会经历持续的症状,尽管足够的口服勒沃西 (L-T4) 治疗.
- 区分真正的吸收不良和伪吸收不良对于管理至关重要.
研究的目的:
- 详细介绍一例异常耐药性甲状腺功能低下症的病例.
- 为了探索静脉注射levothyroxine在一个不响应的患者的疗效.
- 为了为对替代的勒沃西施用途径的有限研究做出贡献.
主要方法:
- 一个27岁的女性病例报告,患有持续的甲状腺功能低下症状.
- 对口服Levothyroxine粘附和吸收的评估.
- 由于耐火性症状,静脉注射levothyroxine的使用.
主要成果:
- 患者表现出持续的甲状腺功能低下的症状,尽管坚持口服levothyroxine.
- 静脉注射Levothyroxine导致症状完全消失.
- 在治疗后的四年里,维持了持续的甲状腺功能状态.
结论:
- 静脉注射的勒沃甲状腺素可以为患有异常耐药性甲状腺功能低下症的患者提供有效的替代方案.
- 这一案例凸显了当口服吸收不足时,IV勒沃西的潜力.
- 需要进一步的研究来探索IV勒沃西在耐火性甲状腺功能低下症中的作用.
相关概念视频
Synthesis and Regulation of Thyroid Hormones
7.1K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
7.1K
Dysrhythmias VI: Management of Dysrhythmias
422
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
422
Myocarditis IV: Nursing Management
199
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
199
Angina IV: Management
223
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
223
Chronic Kidney Disease IV: Nursing Management
308
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
308
Psychosis: Goals of Pharmacotherapy
453
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
453

